119th Congress · introduced in the House · Oct 31, 2025
Fight Illicit Pill Presses Act
Official title from Congress.gov
Latest action (Jul 15, 2026): Forwarded by Subcommittee to Full Committee by Voice Vote.
View on Congress.govPolicy area: Crime and Law Enforcement
Congressional Research Service summary, version: Introduced in House (Oct 31, 2025)
Fight Illicit Pill Presses Act
This bill broadens the scope of pill machines that are subject to regulation under the Controlled Substances Act (CSA). The bill also requires regulated machines to have serial numbers and imposes criminal penalties for conduct involving the removal of serial numbers or the transportation of regulated machines knowing the serial numbers have been removed.
Currently, the CSA requires persons who manufacture, distribute, import, export, or purchase certain regulated machines to keep records of and report on transactions involving the machines. Currently, the term regulated machines includes tableting machines and encapsulating machines.
This bill requires persons who sell or deliver regulated machines to comply with the CSA's recordkeeping and reporting requirements, in addition to persons who manufacture, distribute, import, export, or purchase them.
The bill also expands regulated machines, for which transactions must be recorded and reported, to include critical parts of tableting and encapsulating machines such as dies used to mold pills and punches used to imprint markings and logos onto pills.
The bill requires serial numbers to be permanently affixed to encapsulating machines, tableting machines, and critical parts of tableting and encapsulating machines.
Show the full summary (1 more paragraphs)Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Forwarded by Subcommittee to Full Committee by Voice Vote.
Subcommittee Consideration and Mark-up Session Held
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Administrative law and regulatory procedures · Criminal procedure and sentencing · Customs enforcement · Department of Justice · Drug trafficking and controlled substances · Health technology, devices, supplies · Manufacturing · Retail and wholesale trades
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
3 citations.
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · lobbying firm or registrant: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Pharmacy
$250,000
Spent on own lobbying
…g-term care settings (generally, no specific legislation). The Stop Pills That Kill Act (H.R. 8005), PRESS Act (H.R. 7184), and Fight Illicit Pill Presses Act (H.R. 5880), issues related to halting the unlawful production and availability of fentanyl, fentanyl analogues, and fentanyl-related substances. The States Handling Acce…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOUTHEAST GEORGIA HOSPITAL SYSTEM · lobbying firm or registrant: CAROL G HOLLADAY & ASSOCIATES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…Committee on Energy and Commerce. H.R. 7994 - HERO Act (Ruiz): Enhances harm reduction and overdose prevention services House Committee on Energy and Commerce. H.R. 5880 - Fight Illicit Pill Presses Act (Hageman, Stansbury) & H.R. 8005 - Stop Pills That Kill Act (Evans): Target illicit drug manufacturing and distribution House…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · lobbying firm or registrant: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Pharmacy
$260,000
Spent on own lobbying
…g-term care settings (generally, no specific legislation). The Stop Pills That Kill Act (H.R. 8005), PRESS Act (H.R. 7184), and Fight Illicit Pill Presses Act (H.R. 5880), issues related to halting the unlawful production and availability of fentanyl, fentanyl analogues, and fentanyl-related substances. The States Handling Acce…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing